Navigation Links
Critical Pharmaceuticals Enter Sustained Release hGH Arena
Date:10/1/2008

Preclinical Results of New Somatropin Formulation Demonstrate Advantages

Over Existing Once-Daily Product

NOTTINGHAM, England, October 1 /PRNewswire/ -- Critical Pharmaceuticals, the Nottingham, UK-based speciality pharmaceuticals company, today announced that the successful completion of preclinical trials of a sustained release formulation of the synthetic human growth hormone (hGH) somatropin. Trials demonstrated therapeutic plasma concentrations were achieved over an extended period of time supporting the development of the product as a once every two weekly injection. In addition, the efficacy profile using biomarkers was comparable to current daily formulations.

The new formulation was produced using Critical's patented CriticalMix delivery technology, which is based on world leading supercritical fluid expertise. This enables the optimal encapsulation of drugs into injectable microparticles with superior drug release properties. hGH delivery is a natural application for this technology, and the company now intends to take this product forward into Phase 1 clinical trials. This decision coincides with a recent report by Frost & Sullivan valuing the European market at $846.4m in 2007, with a compound annual growth rate (CAGR) of 2.4 per cent from 2007 to 2014. The report also highlighted new delivery methods together with approval for new indications as keys to success.

According to Chief Business Officer Gareth King, these preclinical results mark an important milestone for the company: "Over the past few years, we have concentrated on optimizing our delivery technologies and ensuring they are transferable from the lab into an industrial setting. Sustained release hGH is one of three projects we are now developing in areas of unmet need. There is no doubt that a sustained release version of hGH would be preferred by patients, particularly paediatric, but there are naturally concerns over safety and efficacy. We
'/>"/>

SOURCE Critical Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill
2. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
3. REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
4. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
5. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
6. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
11. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...TION, N.J., Dec. 1 Merck & Co.... Administration (FDA) has approved ZEGERID OTC(TM)...ules), for over-the-counter treatment of frequent ...counter by Schering-Plough HealthCare Products, In...; Co., Inc. Schering-Plough and Merck merged on No...
(Date:12/1/2009)... Dec. 1 Reportlinker.com announces... its catalogue: ,, Contract Research Outsourci...Opportunities ,, http://www.reportlinker.com/...bal-Update-of-Market-Trends--Opportunities.html ,...me into being in the seventies, evolved into an es...
(Date:12/1/2009)...ERRY HILL, N.J., Dec. 1 ...urprised and delighted when his radiotherapy treat...20 minutes each day to less than five. Midway thr...ware Valley Urology Cancer Center acquired the r...ogy from Varian Medical Systems (NYSE: VAR ), m...
Breaking Medicine Technology:FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 8Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 1Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 2Gambling Addiction Expert Says Treatment Tops Prohibition 57554 1Gambling Addiction Expert Says Treatment Tops Prohibition 57554 2Capital Gold Group Donates to American Red Cross Disaster Relief for Victims of Southern California Wildfires 57552 1Capital Gold Group Donates to American Red Cross Disaster Relief for Victims of Southern California Wildfires 57552 2
... Conn., June 25 CuraGen Corporation,(Nasdaq: CRG...cused on,oncology, announced today the treatment o...reast cancer study., The Phase II trial is an ope...stered intravenously once every three weeks to pat...ancer who have received prior,therapy. This study ...
...mendations Address Presurgery and Pediatric Dilemm... guidelines,address the prevention and management ...orce recommendations related to the routine use of...n the June issue of CHEST,the peer-reviewed journa...P), Antithrombotic and Thrombolytic Therapy: ACCP ...
Other Medicine Technology:CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer 2CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer 3CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer 4Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 2Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 4
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Emerging Clinical Trial Locations - In...nd regulatory environment ,, http://www.repo...tions---India-Market-dynamics-and-the-changing-hea...r the last decade pharmaceutical and biotechnology...
(Date:12/1/2009)...re-USNewswire/ -- The Kerlan Jobe Orthopaedic Clin...greed to pay the United States $3 million to settl...rom HealthSouth Corporation, the Justice Departmen...ves allegations that HealthSouth paid kickbacks to...onations to the Kerlan Jobe Foundation, loan forgi...
(Date:12/1/2009)...wire/ -- A decision issued today by a regional dir... has put at risk the guaranteed raises, healthcare...social workers, and professionals in Southern Cali... standards at Kaiser that give us security and all...s need," said Jeanette Cryer, Licensed Clinical So...
(Date:12/1/2009)...iteria based on computed tomography (CT) imaging o...es after chemotherapy with the drug bevacizumab ma...according to a study in the December 2 issue of J...c (toxic to cells) chemotherapy is associated with...ectal cancer and higher pathologic response rates ...
(Date:12/1/2009)...RNewswire-USNewswire/ -- The American Society of H...tudent Symposium at the New Orleans Marriott on Th...m, which encourages an interest in hematology, the...d in conjunction with the Society,s 51st Annual Me...ty to explore research on sickle cell disease, an ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3
...g patients, own bone marrow stem cells (progenitor...r a heart attack in a study at Emory University Sc...y cardiologist Arshed Quyyumi, MD, and hematologis...his is one of the first trials where patients rece...
... Designed to Assist Doctors and Parents in Prevent...KLAND, Calif., Dec. 11 Kaiser Permanente and,Disc...program have teamed,up to launch "Healthy Steps to...ssary steps to treat and prevent this,epidemic. Th...
...nger Interventions but Say Facilities Must Do More...ntion professionals conducted six months after the...l and Epidemiology,s (APIC,s) national,MRSA Preval...ant Staphylococcus aureus (MRSA), 50 percent said ...
...The holiday season is a time for,office parties, s...lorie,goodies with the cold winter weather, and De...up, Fitness Operations VP at 24 Hour Fitness healt...at:, http://media.medialink.com/WebNR.aspx?story=3...
....C. If companies provide workplace flexibility an...then healthier lifestyle habits are put into actio... lead author Joseph G. Grzywacz, Ph.D., of Wake Fo...nalysis, is published in the Dec. 11 issue of The ...
...eduled for tomorrow, Tuesday, December 11, 2007 at...CETON, N.J., Dec. 10 Medarex, Inc.,(Nasdaq: MEDX...today announced,top-line data from the three regis...atic melanoma. The results from,study 008, conduct...
Other Medicine News:Health News:Adult stem cell heart attack study updated at American Society for Hematology Meeting 2Health News:Kaiser Permanente and Discovery Health Team Up to Fight Childhood Obesity Epidemic 2Health News:Kaiser Permanente and Discovery Health Team Up to Fight Childhood Obesity Epidemic 3Health News:Kaiser Permanente and Discovery Health Team Up to Fight Childhood Obesity Epidemic 4Health News:Poll of Infection Prevention and Control Professionals Reveals MRSA Prevention Progress Six Months After National Survey 2Health News:Poll of Infection Prevention and Control Professionals Reveals MRSA Prevention Progress Six Months After National Survey 3Health News:Employees with workplace flexibility have healthier lifestyle habits 2Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 2Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 3Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 4Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 5Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 6Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 7
SP-2000P Non -Contact Specular Microscope
KOWA VX-10 / VK-2 Digital Imaging System
...te-of-the-art electronic medical record the develo..., comprehensive electronic medical record designed...the point of care and to be shared selectively via...rts chronicles patient history, encounters, medica...
...friendly computerized medical record system whose ...y of the practice as well as improve the degree an...lates for commonly presenting problems based on th...database to cover rare diagnostic entities. It cov...
Medicine Products: